The drug colchicine may reduce cardiovascular outcomes among patients with gout, based on a range of retrospective data that ...

Taking low-dose colchicine daily may slow the progression of a common acquired gene mutation found in the blood of older adults that can lead to certain blood cancers and increased risk of ...

MONTREAL, June 23, 2023 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) welcomes the approval by the United States Food and Drug Administration (FDA) of colchicine for cardiovascular prevention ...

The findings underscore the need to explore alternative therapeutic approaches to managing persistent symptoms, the authors ...